Growth Metrics

Pulmonx (LUNG) Return on Equity (2020 - 2025)

Pulmonx has reported Return on Equity over the past 6 years, most recently at 0.01% for Q4 2025.

  • Quarterly Return on Equity changed 0.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.01% for FY2024, 0.0% changed from the prior year.
  • Return on Equity was 0.01% for Q4 2025 at Pulmonx, up from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q1 2021 and troughed at 0.01% in Q3 2025.
  • The 5-year median for Return on Equity is 0.0% (2023), against an average of 0.0%.
  • The largest YoY upside for Return on Equity was 3bps in 2021 against a maximum downside of 0bps in 2021.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then crashed by -51bps to 0.0% in 2022, then tumbled by -34bps to 0.0% in 2023, then dropped by -26bps to 0.01% in 2024, then fell by -22bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Return on Equity are 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).